Antisense & RNAi Therapeutics Market expected to witness a CAGR of 7.5% during the forecast period 2019 - 2025
Antisense & RNAi Therapeutics Industry Overview The global antisense & RNAi therapeutics market size was estimated at USD 1.09 billion in 2018 and is expected to witness a CAGR of 7.5% during the forecast period. Antisense technology provides the opportunity to manipulate the gene expression, and this is being considered as an effective treatment for various diseases. This opportunity is being cashed on by the companies and investing in R&D in this sector. The possibility of studying gene function for disease management by regulating the gene expression by the malfunctioning gene, R&D carried out with respect to the treatment of uncommon neurodegenerative diseases, such as hereditary ATTR amyloidosis, are some of the other factors anticipated to drive the market. Gather more insights about the market drivers, restrains and growth of the Global Antisense & RNAi Therapeutics Market Antisense and RNAi therapeutics enable specific and highly effective gene ...